Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Acyl Coenzyme A Dehydrogenase Deficiency 1Mesothelioma, Malignant 1Melanoma 1Lymphoma 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Brain Neoplasms 1

Interventions

Specimen Handling 40Biopsy 39Magnetic Resonance Spectroscopy 31Cyclophosphamide 21aldesleukin 20fludarabine 16fludarabine phosphate 13Leucovorin 12Fluorouracil 12Interleukin-2 11Paclitaxel 9Melphalan 9Oxaliplatin 8trastuzumab deruxtecan 7Irinotecan 7X-Rays 6Taxes 6Nivolumab 6olaparib 5Ipilimumab 5CTLA-4 Antigen 5trametinib 4Neoadjuvant Therapy 4Floxuridine 4Doxorubicin 4Chemotherapy, Adjuvant 4Carboplatin 4veliparib 3talazoparib 3pembrolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neoplasm Metastasis × Ganciclovir × Clear all
NCT00001328 2017-07-02

Gene Therapy for the Treatment of Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis, Neoplasms, Multiple Acyl Coenzyme A Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡